Latest Developments in Global Chronic Idiopathic Constipation Treatment Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Latest Developments in Global Chronic Idiopathic Constipation Treatment Market

  • Pharmaceutical
  • Dec 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60
  • In March 2024, Sanofi Consumer Health entered into a strategic partnership with Alliance Healthcare and Phoenix Healthcare Distribution to enhance the availability of its key products in the United Kingdom. This collaboration aims to streamline the supply chain process, ensuring better stock availability of products such as Allevia, Buscopan, Dulcolax, and Phenergan in pharmacies across the U.K. The partnership also focuses on increasing operational efficiency and expanding the company’s market reach
  • In January 2024, Bayer AG’s consumer health division launched “The Gut Gap” campaign in the U.S. to raise awareness about the prevalent issues of stress and constipation, particularly among American women. The initiative, backed by a commissioned survey, highlights the need for solutions such as MiraLax to address constipation. This campaign aims to amplify product outreach and provide support for women experiencing digestive discomfort

Frequently Asked Questions